From Comparative Pathogenesis to Biomarker-guided Treatments in Psoriasis and Eczema

At ESDR 2024 | September 4, 2024 | Time: 13:00-17:00 (1:00-5:00 PM WEST | local time) 

Lisbon Congress Center | Praça das Indústrias,1300-307 | Centro de Congressos de Lisboa (CCL) Auditorium II, Level 1 | Lisbon, Portugal

A joint program of the IEC and International Psoriasis Council (IPC).

DOWNLOAD THE PROGRAM GUIDE 

WATCH ON-DEMAND WEBCAST

PROGRAM CHAIRS

AGENDA 

13:00-13:10 Welcome and introduction
Johann Gudjonsson, MD, PhD | IPC Councilor | University of Michigan, Ann Arbor, Michigan, United States
Nick Reynolds, BSc, MBBS, MD, FRCP | IEC & IPC Councilor | Newcastle University, Newcastle upon Tyne, United Kingdom

13:10-13:30 The Comparative Pathogenesis of Psoriasis and Atopic Dermatitis 
Johann Gudjonsson, MD, PhD | IPC Councilor |University of Michigan, Ann Arbor, Michigan, United States 

13:30-13:50 Phenotype Switching 
Michel Gilliet, MD | IPC Councilor | University of Lausanne, Lausanne, Switzerland

13:50-14:10 Genetic and Ethnic Differences in Psoriasis and Atopic Dermatitis
Sara Brown, MBChB, MD | IEC Councilor | University of Edinburgh, Edinburgh, Scotland, United Kingdom

14:10-14:25 Panel Discussion | All Faculty

14:25-14:40 BREAK

14:40-15:25 Abstract Presentations

Epigenetic and Transcriptomic Characterization of Skin Homing CLA+ CD4+ T Cells in Atopic Dermatitis and Psoriasis
Ana Rebane, PhD, Tartu, Estonia

Protective Effects of Systemic Therapies for Psoriasis Against Thrombotic Events
Alison Treichel, MD, Cleveland, OH, US

Reduced Filaggrin Expression Reduces ERK Signaling and Disrupts Desmosomes in Atopic Eczema
Ryan O’Shaughnessy, SFHEA PhD, London, England, UK

The Effect of Age on the Severity of Psoriasis
Shir Azrielant, MD, St John’s Institute of Dermatology, King’s College London, London, United Kingdom

Smart Imaging and Deep Learning for Objective Psoriasis Lesion Scoring: A Scarletred Proof-of-Concept Study
Monika Molnarova, SCARLETRED Holding GmbH, Vienna, Austria

15:25-15:45 Using Biomarkers to Inform the Treatment of Atopic Dermatitis
Marjolein de Bruin Weller, MD, PhD | IEC Councilor | Utrecht University, Utrecht, Netherlands

15:45-16:05 Using Biomarkers to Inform the Treatment of Psoriasis
Satveer Mahil, MB BChir MA PhD | IPC Councilor | St John’s Institute of Dermatology, Guys and St Thomas’ Hospitals, London, United Kingdom

16:05-16:25 Using Biomarkers to Assess the Risk of Comorbidities in Atopic Dermatitis
Christian Vestergaard, MD, PhD, DMSc | IEC Councilor | Aarhus University, Aarhus, Denmark

16:25-16:45 Using Biomarkers to Assess the Risk of Comorbidities in Psoriasis
Catherine Smith, MD | IPC Board Member | St John’s Institute of Dermatology, Guys and St Thomas’ Hospitals, London, United Kingdom

16:45-17:00 Panel Discussion | All Faculty

17:00 Closing Comments & Adjourn

Akimichi Morita, MD, PhD | IPC Board Member | Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan

Tiago Torres, MD, PhD | IEC & IPC Councilor | University of Porto, Porto, Portugal

Please check back for updates.  

This educational symposium presented by the IEC is offered at no cost to attendees.

HEALTH AND SAFETY TRAVEL RESOURCES

IEC and IPC will comply with local mandates at the time of the in-person meeting.